EXTL3
Basic information
Region (hg38): 8:28600469-28756561
Links
Phenotypes
GenCC
Source:
- immunoskeletal dysplasia with neurodevelopmental abnormalities (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunoskeletal dysplasia with neurodevelopmental abnormalities | AR | Allergy/Immunology/Infectious | The condition can include severe combined immunodeficiency, and awareness may allow preventive measures and early and aggressive treatment of infections | Allergy/Immunology/Infectious; Musculoskeletal; Neurologic | 28148688; 28132690 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXTL3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 197 | 207 | ||||
missense | 208 | 215 | ||||
nonsense | 6 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 8 | 11 | |||
non coding | 15 | 16 | ||||
Total | 0 | 2 | 222 | 219 | 10 |
Variants in EXTL3
This is a list of pathogenic ClinVar variants found in the EXTL3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-28716061-T-C | Uncertain significance (Nov 27, 2023) | |||
8-28716064-C-CA | Uncertain significance (May 13, 2022) | |||
8-28716065-A-G | Likely benign (Oct 25, 2022) | |||
8-28716068-C-T | EXTL3-related disorder | Likely benign (Sep 21, 2023) | ||
8-28716077-G-A | Uncertain significance (Oct 24, 2022) | |||
8-28716081-C-T | Immunoskeletal dysplasia with neurodevelopmental abnormalities • Inborn genetic diseases | Uncertain significance (Sep 19, 2022) | ||
8-28716082-G-A | Inborn genetic diseases | Uncertain significance (Oct 16, 2023) | ||
8-28716084-A-G | Uncertain significance (May 19, 2022) | |||
8-28716089-G-T | Likely benign (Dec 07, 2022) | |||
8-28716092-C-T | Benign (Dec 11, 2023) | |||
8-28716094-C-T | Uncertain significance (May 22, 2022) | |||
8-28716095-G-A | EXTL3-related disorder | Likely benign (Nov 27, 2023) | ||
8-28716101-C-T | Likely benign (Nov 23, 2022) | |||
8-28716104-A-T | Likely benign (Jan 02, 2021) | |||
8-28716120-C-T | Likely benign (Apr 15, 2023) | |||
8-28716123-C-T | Uncertain significance (Oct 13, 2023) | |||
8-28716124-G-A | Uncertain significance (Aug 16, 2022) | |||
8-28716135-C-T | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
8-28716136-G-A | Inborn genetic diseases | Uncertain significance (Jan 24, 2023) | ||
8-28716138-A-G | Uncertain significance (May 30, 2021) | |||
8-28716141-C-G | Uncertain significance (Feb 18, 2022) | |||
8-28716141-C-T | Inborn genetic diseases | Uncertain significance (Nov 10, 2024) | ||
8-28716142-G-A | Uncertain significance (Aug 02, 2022) | |||
8-28716156-A-T | Uncertain significance (Aug 09, 2022) | |||
8-28716163-C-T | Uncertain significance (Dec 11, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EXTL3 | protein_coding | protein_coding | ENST00000220562 | 5 | 155131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000250 | 0.999 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 458 | 556 | 0.824 | 0.0000394 | 6005 |
Missense in Polyphen | 91 | 176.92 | 0.51436 | 1866 | ||
Synonymous | -1.29 | 259 | 234 | 1.11 | 0.0000165 | 1919 |
Loss of Function | 2.94 | 13 | 30.5 | 0.426 | 0.00000172 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Glycosyltransferase which regulates the biosynthesis of heparan sulfate (HS). Important for both skeletal development and hematopoiesis, through the formation of HS proteoglycans (HSPGs) (PubMed:28132690, PubMed:28148688). Required for the function of REG3A in regulating keratinocyte proliferation and differentiation (PubMed:22727489). {ECO:0000269|PubMed:22727489, ECO:0000269|PubMed:28132690, ECO:0000269|PubMed:28148688}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);XBP1(S) activates chaperone genes;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- loftool
- 0.0851
- rvis_EVS
- -1.79
- rvis_percentile_EVS
- 2.24
Haploinsufficiency Scores
- pHI
- 0.349
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.490
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Extl3
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- extl3
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- organization quality
Gene ontology
- Biological process
- protein glycosylation;heparan sulfate proteoglycan biosynthetic process;positive regulation of cell growth;IRE1-mediated unfolded protein response
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;integral component of membrane
- Molecular function
- glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;transferase activity, transferring glycosyl groups;metal ion binding